Sandeep Gurbuxani to Spleen
This is a "connection" page, showing publications Sandeep Gurbuxani has written about Spleen.
Connection Strength
0.066
-
AKT is a therapeutic target in myeloproliferative neoplasms. Leukemia. 2013 Sep; 27(9):1882-90.
Score: 0.025
-
Overexpression of survivin initiates hematologic malignancies in vivo. Leukemia. 2010 Nov; 24(11):1920-6.
Score: 0.021
-
FLIP: a novel regulator of macrophage differentiation and granulocyte homeostasis. Blood. 2010 Dec 02; 116(23):4968-77.
Score: 0.021